1. Home
  2. LGND vs NUV Comparison

LGND vs NUV Comparison

Compare LGND & NUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • NUV
  • Stock Information
  • Founded
  • LGND 1987
  • NUV 1987
  • Country
  • LGND United States
  • NUV United States
  • Employees
  • LGND N/A
  • NUV N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • NUV Trusts Except Educational Religious and Charitable
  • Sector
  • LGND Health Care
  • NUV Finance
  • Exchange
  • LGND Nasdaq
  • NUV Nasdaq
  • Market Cap
  • LGND 2.0B
  • NUV 1.8B
  • IPO Year
  • LGND 1992
  • NUV N/A
  • Fundamental
  • Price
  • LGND $124.30
  • NUV $8.65
  • Analyst Decision
  • LGND Strong Buy
  • NUV
  • Analyst Count
  • LGND 8
  • NUV 0
  • Target Price
  • LGND $144.71
  • NUV N/A
  • AVG Volume (30 Days)
  • LGND 139.7K
  • NUV 464.9K
  • Earning Date
  • LGND 08-05-2025
  • NUV 01-01-0001
  • Dividend Yield
  • LGND N/A
  • NUV 3.96%
  • EPS Growth
  • LGND N/A
  • NUV N/A
  • EPS
  • LGND N/A
  • NUV N/A
  • Revenue
  • LGND $181,488,000.00
  • NUV N/A
  • Revenue This Year
  • LGND $18.41
  • NUV N/A
  • Revenue Next Year
  • LGND $18.87
  • NUV N/A
  • P/E Ratio
  • LGND N/A
  • NUV N/A
  • Revenue Growth
  • LGND 53.40
  • NUV N/A
  • 52 Week Low
  • LGND $81.74
  • NUV $7.86
  • 52 Week High
  • LGND $129.90
  • NUV $9.08
  • Technical
  • Relative Strength Index (RSI)
  • LGND 64.68
  • NUV 50.75
  • Support Level
  • LGND $120.68
  • NUV $8.62
  • Resistance Level
  • LGND $127.07
  • NUV $8.80
  • Average True Range (ATR)
  • LGND 3.76
  • NUV 0.07
  • MACD
  • LGND 0.86
  • NUV -0.00
  • Stochastic Oscillator
  • LGND 81.95
  • NUV 39.08

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About NUV Nuveen Municipal Value Fund Inc.

Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.

Share on Social Networks: